190 related articles for article (PubMed ID: 27816429)
21. Preparation of single-chain antibody against VP3 protein of duck hepatitis virus type 1 by phage display technology.
Wang Y; Cui P; Zhu S; Meng T; Hao F; Zhu G; Zuo W
J Virol Methods; 2018 Jul; 257():73-78. PubMed ID: 29727718
[TBL] [Abstract][Full Text] [Related]
22. The VP3 protein of duck hepatitis A virus mediates host cell adsorption and apoptosis.
Lai Y; Zeng N; Wang M; Cheng A; Yang Q; Wu Y; Jia R; Zhu D; Zhao X; Chen S; Liu M; Zhang S; Wang Y; Xu Z; Chen Z; Zhu L; Luo Q; Liu Y; Yu Y; Zhang L; Huang J; Tian B; Pan L; Ur Rehman M; Chen X
Sci Rep; 2019 Nov; 9(1):16783. PubMed ID: 31727985
[TBL] [Abstract][Full Text] [Related]
23. Genetic variation of the VP1 gene of the virulent duck hepatitis A virus type 1 (DHAV-1) isolates in Shandong province of China.
Gao J; Chen J; Si X; Xie Z; Zhu Y; Zhang X; Wang S; Jiang S
Virol Sin; 2012 Aug; 27(4):248-53. PubMed ID: 22899433
[TBL] [Abstract][Full Text] [Related]
24. Outbreaks of Duck Hepatitis A Virus in Egyptian Duckling Flocks.
Mansour SMG; Mohamed FF; ElBakrey RM; Eid AAM; Mor SK; Goyal SM
Avian Dis; 2019 Mar; 63(1):68-74. PubMed ID: 31251521
[TBL] [Abstract][Full Text] [Related]
25. The DHAV-1 protein VP1 interacts with PI3KC3 to induce autophagy through the PI3KC3 complex.
Li J; Wang M; Zhou S; Cheng A; Ou X; Sun D; Wu Y; Yang Q; Gao Q; Huang J; Tian B; Mao S; Zhang S; Zhao X; Jia R; Liu M; Zhu D; Chen S; Liu Y; Yu Y; Zhang L; Pan L
Vet Res; 2022 Aug; 53(1):64. PubMed ID: 35978392
[TBL] [Abstract][Full Text] [Related]
26. Replication cycle of duck hepatitis A virus type 1 in duck embryonic hepatocytes.
Yao F; Chen Y; Shi J; Ming K; Liu J; Xiong W; Song M; Du H; Wang Y; Zhang S; Wu Y; Wang D; Hu Y
Virology; 2016 Apr; 491():73-8. PubMed ID: 26874587
[TBL] [Abstract][Full Text] [Related]
27. Live Attenuated Vaccine Based on Duck Enteritis Virus against Duck Hepatitis A Virus Types 1 and 3.
Zou Z; Ma J; Huang K; Chen H; Liu Z; Jin M
Front Microbiol; 2016; 7():1613. PubMed ID: 27777571
[TBL] [Abstract][Full Text] [Related]
28. Molecular epidemiology and genetic diversity of duck hepatitis A virus type 3 in Shandong province of China, 2012-2014.
Zhang R; Xia L; Chen J; Gong Y; Zhang L; Li P; Liu H; Xie Z; Jiang S
Acta Virol; 2017; 61(4):463-472. PubMed ID: 29186963
[TBL] [Abstract][Full Text] [Related]
29. First Report of Duck Hepatitis A Virus 3 from Duckling Flocks of Egypt.
Hassan TIR; Eid AAM; Ghanem IAI; Shahin AM; Adael SAA; Mohamed FF
Avian Dis; 2020 Sep; 64(3):269-276. PubMed ID: 33205161
[TBL] [Abstract][Full Text] [Related]
30. [Sequence analysis of VP1 gene of the duck hepatitis A virus type 3 strains isolated from Shandong Province of China in 2012].
Xu Q; Chen LL; Zhang RH; Yang L; Xie ZJ; Zhu YL; Jiang SJ; Si XK
Bing Du Xue Bao; 2013 Sep; 29(5):522-8. PubMed ID: 24386841
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylated Codonopsis pilosula polysaccharide could inhibit the virulence of duck hepatitis A virus compared with Codonopsis pilosula polysaccharide.
Ming K; Chen Y; Yao F; Shi J; Yang J; Du H; Wang X; Wang Y; Liu J
Int J Biol Macromol; 2017 Jan; 94(Pt A):28-35. PubMed ID: 27713010
[TBL] [Abstract][Full Text] [Related]
32. [Development and evaluation of an inactivated bivalent vaccine against duck viral hepatitis].
Yin F; Jing L; Zhang S; Yu M; Zhang W; Fan G; Dong X; Liu W
Sheng Wu Gong Cheng Xue Bao; 2015 Nov; 31(11):1579-88. PubMed ID: 26939441
[TBL] [Abstract][Full Text] [Related]
33. Protection against duck hepatitis a virus type 1 conferred by a recombinant avian adeno-associated virus.
Wang AP; Liu L; Gu LL; Guo CM; Wu S; Feng Q; Xia WL; Wu Z; Zhu SY
Poult Sci; 2019 Jan; 98(1):112-118. PubMed ID: 30053293
[TBL] [Abstract][Full Text] [Related]
34. The pathogenicity of duck hepatitis A virus types 1 and 3 on ducklings.
Niu Y; Ma H; Ding Y; Li Z; Sun Y; Li M; Shi Y
Poult Sci; 2019 Dec; 98(12):6333-6339. PubMed ID: 31393586
[TBL] [Abstract][Full Text] [Related]
35. Establishment and characterization of duck embryo epithelial (DEE) cell line and its use as a new approach toward DHAV-1 propagation and vaccine development.
Wang W; Said A; Wang Y; Fu Q; Xiao Y; Lv S; Shen Z
Virus Res; 2016 Feb; 213():260-268. PubMed ID: 26739426
[TBL] [Abstract][Full Text] [Related]
36. Expression and immunogenic analysis of recombinant polypeptides derived from capsid protein VP1 for developing subunit vaccine material against hepatitis A virus.
Jang KO; Park JH; Lee HH; Chung DK; Kim W; Chung IS
Protein Expr Purif; 2014 Aug; 100():1-9. PubMed ID: 24816194
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the hepatocyte protective effects of gypenoside and its phosphorylated derivative against DHAV-1 infection on duck embryonic hepatocytes.
Du H; Bai J; Wang J; He M; Xiong W; Yuan W; Qiao M; Ming K; Wu Y; Wang D; Hu Y; Liu J
BMC Vet Res; 2019 May; 15(1):134. PubMed ID: 31064364
[TBL] [Abstract][Full Text] [Related]
38. Molecular genotyping of duck hepatitis A viruses (DHAV) in Vietnam.
Doan HT; Le XT; Do RT; Hoang CT; Nguyen KT; Le TH
J Infect Dev Ctries; 2016 Sep; 10(9):988-995. PubMed ID: 27694732
[TBL] [Abstract][Full Text] [Related]
39. Duck hepatitis A virus type 1 transmission by exosomes establishes a productive infection in vivo and in vitro.
Xu G; Yan H; Zhu Y; Xie Z; Zhang R; Jiang S
Vet Microbiol; 2023 Feb; 277():109621. PubMed ID: 36525908
[TBL] [Abstract][Full Text] [Related]
40. The prevalence of duck hepatitis A virus types 1 and 3 on Korean duck farms.
Soliman M; Alfajaro MM; Lee MH; Jeong YJ; Kim DS; Son KY; Kwon J; Choi JS; Lim JS; Choi JS; Lee TU; Cho KO; Kang MI
Arch Virol; 2015 Feb; 160(2):493-8. PubMed ID: 25359107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
